Mirdametinib
- Part D specialty tier in 80% of formularies (2026Q3)
- Gomekli
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Mirdametinib: storage and handling
- Freezing
- Not addressed
- Room temperature
- at or below 25°C (77°F)
Label statement
Storing GOMEKLI tablets for oral suspension Store GOMEKLI tablets for oral suspension at room temperature between 68°F to 77°F (20°C to 25°C).
- Room temperature
- at or below 25°C (77°F)
Label statement
Store GOMEKLI at room temperature between 68°F to 77°F (20°C to 25°C).
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Protect from light.
- Shaking
- Not addressed
All storage statements on the label (6)
- Bottle of 42 tablets 82448-134-42 Bottle of 84 tablets 82448-134-84 Storage and Handling Store capsules and tablets for oral suspension at 20°C to 25°C (68°F to 77°F).
- Excursions permitted between 15°C to 30°C (59°F to 86°F).
- See USP Controlled Room Temperature.
- Protect from light.
- Storing GOMEKLI tablets for oral suspension Store GOMEKLI tablets for oral suspension at room temperature between 68°F to 77°F (20°C to 25°C).
- Store GOMEKLI at room temperature between 68°F to 77°F (20°C to 25°C).
FDA label version 8, effective July 10, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.